STAT+: AI scientist company Edison Scientific tapped by team behind Metsera to create new biotechs

Edison Scientific and Population Health Partners are collaborating to harness the power of AI for drug discovery and development, aiming to revolutionize the biotech industry. This partnership leverages advanced AI agents to accelerate the identification and development of new medications, potentially speeding up breakthroughs in treatments for various diseases. Given the current slow pace of drug development, this innovative approach could significantly impact healthcare by making new therapies more accessible and affordable, marking a pivotal shift in how biotech companies operate.